It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Christina Y. Weng, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Alimera Sciences, Allergan/AbbVie, DORC, Genentech, Novartis, Regeneron Pharmaceuticals, and Regenxbio.
Diana V. Do, MD, has had a financial agreement or affiliation in the form of Consultant: Boehringer Ingelheim, Kodiak Sciences, Mallinckrodt Pharmaceuticals, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Boehringer Ingelheim, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Kodiak Sciences.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.